XML 38 R27.htm IDEA: XBRL DOCUMENT v3.19.2
Commitments and Contingencies (Details Narrative) - USD ($)
1 Months Ended 6 Months Ended
Mar. 26, 2019
Feb. 28, 2019
May 24, 2018
Apr. 10, 2018
Jan. 04, 2018
Jun. 08, 2017
Sep. 30, 2018
Jul. 31, 2018
Apr. 30, 2018
Jun. 30, 2012
Jun. 30, 2019
Apr. 28, 2019
Purchase price of Plaintiffs   $ 3,375,000                    
Monthly consultation fee         $ 11,000              
CardioSert Ltd [Member]                        
Initial payment       $ 250,000 $ 50,000              
Number of common shares acquired     6,738 6,738             6,738  
Number of common shares acquired, value       $ 74,000                
Buy back amount per patent         $ 1.00              
CardioSert Ltd [Member] | Before Reverse Split [Member]                        
Number of common shares acquired     100,000 100,000                
Bonding Agent [Member]                        
Purchase price of Plaintiffs $ 4,200,000                      
Additional expenses respect to interest from the judgement date $ 101,000                      
Securities Purchase Agreement [Member]                        
Purchase price of Plaintiffs           $ 3,375            
Loss contingency, damages sought           $ 1,000,000            
Minimum [Member] | Alliance Investment Management, Ltd. [Member]                        
Beneficial ownership percentage                       10.00%
Minimum [Member] | CardioSert Ltd [Member]                        
Investments         $ 2,000,000              
Minimum [Member] | Technion Research And Development Foundation Limited [Member]                        
Royalties payable as percentage of future sales                   1.50%    
Maximum [Member] | Technion Research And Development Foundation Limited [Member]                        
Royalties payable as percentage of future sales                   3.00%    
Second Phase [Member] | Contract Research Agreements [Member]                        
Contract expected costs             $ 248,000   $ 130,000      
Phase 2.1 [Member] | Contract Research Agreements [Member]                        
Contract expected costs               $ 213,000        
Israeli Innovation Authority [Member] | 2013 Through June 30, 2019 [Member]                        
Total grants obtained                     $ 1,500,000  
Israeli Innovation Authority [Member] | 2013 Through June 30, 2019 [Member] | Minimum [Member]                        
Royalties payable as percentage of future sales                     3.00%  
Israeli Innovation Authority [Member] | 2013 Through June 30, 2019 [Member] | Maximum [Member]                        
Royalties payable as percentage of future sales                     3.50%